TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 100nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 120nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 120nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 200nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 200nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 200nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 300nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 460nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 550nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 730nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 810nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 3.00E+3nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 3.60E+3nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 3.90E+3nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 5.40E+3nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 6.30E+3nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 7.60E+3nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 1.50E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 2.30E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 2.50E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >2.50E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: 2.50E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >3.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >3.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >3.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >3.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >3.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >3.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >4.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Homo sapiens (Human))
The Children'S Hospital
US Patent
The Children'S Hospital
US Patent
Affinity DataIC50: >5.00E+4nMAssay Description:The inhibitor compounds were screened initially using one concentration point on a Perkin-Elmer Lambda 40 UV-Vis spectrometer. The percent inhibition...More data for this Ligand-Target Pair